3 results
Approved WMOCompleted
The primary objective of this study is to obtain clinical proof of principle that the addition of a PgP/BCRP inhibitor increases CNS concentrations of tyrosine kinase inhibitors by inhibition of drug efflux transporter function in the blood brain…
Approved WMORecruiting
The objective of the study is a prospective study to evaluate which type of TE shunt prosthesis is the most cost-effective.
Approved WMOCompleted
To determine the pharmacokinetic properties of a new elacridar formulation